Final Director's Interest Notice - Mr McKeough
Released
Released
Announcement PDF
Appendix 3Z
Final Director’s Interest Notice
+ See chapter 19 for defined terms.
11/3/2002 Appendix 3Z Page 1
Rule 3.19A.3
Appendix 3Z
Final Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and
documents given to ASX become ASX’s property and may be made public.
Introduced 30/9/2001.
Name of entity Recce Pharmaceuticals Ltd (Company)
ABN 73 124 849 065
We (the entity) give ASX the following information under listing rule 3.19A.3 and as agent for
the director for the purposes of section 205G of the Corporations Act.
Name of director Alistair McKeough
Date of last notice 16 May 2025
Date that director ceased to be director 6 November 2026
Part 1 – Director’s relevant interests in securities of which the director is the registered holder
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should
be disclosed in this part.
Number & class of securities
Nil.
Appendix 3Z
Final Director’s Interest Notice
+ See chapter 19 for defined terms.
Appendix 3Z Page 2 11/3/2002
Part 2 – Director’s relevant interests in securities of which the director is not the registered holder
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should
be disclosed in this part.
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Name of holder & nature of interest
Note: Provide details of the circumstances giving
rise to the relevant interest
Finn Frist Pty Ltd as trustee for the
AZM Superannuation Fund of which
Mr McKeough is a director and
shareholder of the trustee and a
beneficiary of the trust (Finn Frist
Pty Ltd)
Amabel Pty Limited as trustee for
the McKeough Family Trust of
which Mr McKeough is a director of
the trustee and a beneficiary of the
trust (Amabel Pty Limited)
Number & class of securities
Finn Frist Pty Ltd
1. 30,287 fully paid ordinary shares
Amabel Pty Limited
1. 1,125,000 unlisted options each exercisable
at $1.56, expiring 15 November 2027
2. 1,000,000 unlisted options each exercisable
at $0.80, expiring 14 November 2029
Part 3 – Director’s interests in contracts
Detail of contract N/A
Nature of interest N/A
Name of registered holder
(if issued securities)
N/A
No. and class of securities to which
interest relates
N/A
Share your feedback
Discover